EuroPCR 2014 session defines future horizons for renal denervation
The SYMPLICITY-HTN-3 clinical trial confirmed the safety of renal denervation, but questions remain about its efficacy in patients with difficult-to-control hypertension. Further research is needed to identify the best patients who will benefit from treatment with the procedure.